News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
846,885 Results
Type
Article (86499)
Company Profile (702)
Press Release (759684)
Multimedia
Podcasts (130)
Webinars (14)
Section
Business (232687)
Career Advice (4127)
Deals (39721)
Drug Delivery (129)
Drug Development (90986)
Employer Resources (198)
FDA (18108)
Job Trends (17336)
News (396468)
Policy (39749)
Tag
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (56838)
ALS (102)
Alzheimer's disease (1504)
Antibody-drug conjugate (ADC) (161)
Approvals (18069)
Artificial intelligence (331)
Autoimmune disease (30)
Automation (16)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (481)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (310)
Cancer (2474)
Cardiovascular disease (210)
Career advice (3535)
Career pathing (34)
CAR-T (175)
Cell therapy (498)
Cervical cancer (22)
Clinical research (73454)
Collaboration (928)
Company closure (1)
Compensation (572)
Complete response letters (30)
COVID-19 (2868)
CRISPR (50)
C-suite (274)
Cystic fibrosis (109)
Data (2338)
Decentralized trials (2)
Denatured (45)
Depression (57)
Diabetes (303)
Diagnostics (6926)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (152)
Drug pricing (129)
Drug shortages (33)
Duchenne muscular dystrophy (103)
Earnings (96832)
Editorial (45)
Employer branding (25)
Employer resources (167)
Events (130155)
Executive appointments (785)
FDA (19498)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (830)
Gene editing (125)
Generative AI (35)
Gene therapy (365)
GLP-1 (858)
Government (5164)
Grass and pollen (6)
Guidances (108)
Healthcare (20888)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (150)
Indications (30)
Infectious disease (3032)
Inflammatory bowel disease (159)
Inflation Reduction Act (11)
Influenza (59)
Intellectual property (102)
Interviews (813)
IPO (17825)
IRA (51)
Job creations (5189)
Job search strategy (2861)
Kidney cancer (11)
Labor market (44)
Layoffs (560)
Leadership (24)
Legal (10114)
Liver cancer (82)
Lung cancer (347)
Lymphoma (160)
Machine learning (8)
Management (65)
Manufacturing (367)
MASH (78)
Medical device (14641)
Medtech (14646)
Mergers & acquisitions (22454)
Metabolic disorders (803)
Multiple sclerosis (88)
NASH (23)
Neurodegenerative disease (117)
Neuropsychiatric disorders (34)
Neuroscience (2119)
NextGen: Class of 2025 (7682)
Non-profit (5082)
Now hiring (41)
Obesity (431)
Opinion (275)
Ovarian cancer (80)
Pain (104)
Pancreatic cancer (91)
Parkinson's disease (162)
Partnered (24)
Patents (256)
Patient recruitment (119)
Peanut (51)
People (65332)
Pharmaceutical (143)
Pharmacy benefit managers (22)
Phase I (22667)
Phase II (31894)
Phase III (24028)
Pipeline (1329)
Policy (176)
Postmarket research (3552)
Preclinical (10230)
Press Release (72)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (270)
Rare diseases (434)
Real estate (7392)
Recruiting (75)
Regulatory (26824)
Reports (57)
Research institute (2658)
Resumes & cover letters (649)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (82)
Series A (143)
Series B (94)
Service/supplier (30)
Sickle cell disease (59)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4293)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (51)
The Weekly (83)
Vaccines (819)
Venture capitalists (44)
Weight loss (306)
Women's health (40)
Worklife (20)
Date
Today (311)
Last 7 days (916)
Last 30 days (3122)
Last 365 days (35705)
2025 (12424)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (60)
Alaska (7)
Arizona (269)
Arkansas (14)
Asia (50155)
Australia (8831)
California (6579)
Canada (2086)
China (571)
Colorado (287)
Connecticut (304)
Delaware (165)
Europe (115072)
Florida (959)
Georgia (222)
Hawaii (1)
Idaho (64)
Illinois (640)
India (31)
Indiana (338)
Iowa (12)
Japan (174)
Kansas (111)
Kentucky (28)
Louisiana (15)
Maine (70)
Maryland (983)
Massachusetts (5050)
Michigan (251)
Minnesota (427)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (67)
New Hampshire (70)
New Jersey (1856)
New Mexico (31)
New York (1857)
North Carolina (1143)
North Dakota (9)
Northern California (2822)
Ohio (223)
Oklahoma (15)
Oregon (48)
Pennsylvania (1449)
Puerto Rico (13)
Rhode Island (36)
South America (1653)
South Carolina (26)
South Dakota (1)
Southern California (2435)
Tennessee (106)
Texas (992)
United States (25234)
Utah (196)
Virginia (176)
Washington D.C. (72)
Washington State (611)
West Virginia (3)
Wisconsin (72)
There are 846,885 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adaptimmune to Report Q1 2025 Financial and Business Updates on Tuesday, May 13, 2025
May 7, 2025
·
1 min read
Press Releases
GENOFAB ANNOUNCES PUBLICATION OF GROUNDBREAKING SELF-DOCUMENTING PLASMID TECHNOLOGY IN TRENDS IN BIOTECHNOLOGY
May 7, 2025
·
1 min read
Cancer
C4 Therapeutics Shelves BRAF Blocker, Goes All-In on Multiple Myeloma Drug
The Massachusetts biotech will focus its efforts and resources into cemsidomide, an oral drug candidate being trialed for multiple myeloma and non-Hodgkin lymphoma.
May 7, 2025
·
1 min read
·
Tristan Manalac
Job Trends
Hiring Outlook: Biopharma Job Market Yet To Surge, but Layoffs Decline
Although the job market did not pick up in April, layoffs were down year over year and month over month, according to
BioSpace
tallies. Meanwhile, Amgen, Novartis, Regeneron and Roche announced U.S. manufacturing investments that are sparking job creation.
May 7, 2025
·
3 min read
·
Angela Gabriel
Vaccines
Is the New HHS Vaccine Requirement Anti-Vaccine Activism Disguised as Policy?
Yes, according to leading vaccine physician Paul Offit, who denounced the new placebo-controlled trial requirements for vaccines and sought greater clarity: “I don’t know what they’re talking about.”
May 7, 2025
·
6 min read
·
Heather McKenzie
Press Releases
Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments
May 7, 2025
·
14 min read
Press Releases
Telomir Pharmaceuticals Demonstrates Telomir-1 Reverses Key Drivers of Cellular Decline in Human Cell Lines Supporting Therapeutic Potential in Autism and Spasmodic Dysphonia
May 7, 2025
·
6 min read
Press Releases
CASI Pharmaceuticals Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement
May 7, 2025
·
6 min read
Press Releases
Vistin Pharma ASA (VISTN): Update from the Election Committee
May 7, 2025
·
1 min read
Press Releases
ImmuneWalk Therapeutics Announces $7 Million Seed Financing and Upcoming Presentations of Positive Clinical Results at Upcoming Medical and Industry Conferences
May 7, 2025
·
3 min read
1 of 84,689
Next
